Skip to main content
Top
Published in: Pediatric Nephrology 6/2024

17-01-2024 | Polycystic Kidney Disease | Clinical Insights

Use of a donor kidney with known autosomal dominant polycystic kidney disease in a highly sensitised paediatric recipient

Authors: Theresa Peltz, Vlad Shumeyko, Ben Reynolds

Published in: Pediatric Nephrology | Issue 6/2024

Login to get access

Abstract

We report the use of an autosomal-dominant polycystic kidney disease (ADPKD) donor kidney in a paediatric recipient. A 14-year-old boy on haemodialysis for 4 years following loss of a first kidney transplant, highly sensitised, and with limited vascular options for ongoing dialysis access, was offered a deceased brain death donor transplant from a mid-30s donor with known ADPKD but normal kidney function and negligible proteinuria. After extensive discussion with the patient and family, discussing all alternative options and review of available literature, the kidney was accepted and implanted. Graft function was immediate. An early post-transplant creatinine rise was attributed to possible antibody-mediated rejection, treated with plasmapheresis and rituximab. Ten months post-transplant, the patient remains dialysis-free with stable function. Extended criteria kidneys are already considered for highly sensitised or long-waiting dialysis patients. Though the literature is limited, kidneys from patients with ADPKD could be considered within extended criteria offers on a case-by-case basis.
Literature
Metadata
Title
Use of a donor kidney with known autosomal dominant polycystic kidney disease in a highly sensitised paediatric recipient
Authors
Theresa Peltz
Vlad Shumeyko
Ben Reynolds
Publication date
17-01-2024
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 6/2024
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-024-06283-y

Other articles of this Issue 6/2024

Pediatric Nephrology 6/2024 Go to the issue